Tolfenamic acid attenuated learning and memory deficits in AD transgenic mice through inhibiting the expression of APP, BACE1, and SP1-mediated CDK5/hyperphosphorylated tau [11, 12]. The gene discussed is SP1; the disease is Alzheimer disease.